Viewing Study NCT06176235


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-06-06 @ 6:09 PM
Study NCT ID: NCT06176235
Status: WITHDRAWN
Last Update Posted: 2025-08-11
First Post: 2023-12-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia
Sponsor: Peking University People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Immune Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Teriflunomide View
None Dexamethasone View